Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy

Lupus nephritis: where are we now?

(2010) Liz Lightstone   CURRENT OPINION IN RHEUMATOLOGY

Rituximab-Associated Infections

(2010) Juan C. Gea-Banacloche   SEMINARS IN HEMATOLOGY

A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at university college london hospital: The first fifty patients

(2009) Tim Y.-T. Lu et al.   ARTHRITIS AND RHEUMATISM

Rituximab and lupus: Good in real life, bad in controlled trials. comment on the article by Lu et al

(2009) Manuel Ramos-Casals et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

(2009) Joan T. Merrill et al.   ARTHRITIS AND RHEUMATISM

Rituximab in Severe Lupus Nephritis: Early B-Cell Depletion Affects Long-Term Renal Outcome

(2009) C. Melander et al.   Clinical Journal of the American Society of Nephrology

Rituximab in cryoglobulinemic peripheral neuropathy

(2009) Roberto Cavallo et al.   JOURNAL OF NEUROLOGY

Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids

(2009) R. Pepper et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

B cell–directed therapies for autoimmune disease and correlates of disease response and relapse

(2008) Marc C. Levesque et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY